E-Pharma Market Is Projected To Grow At A CAGR Of 14.8% During Forecast Period 2014-2025

Global E-Pharma Market is expected to reach USD 109.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by constant increase in the number of internet users, improved access to web-based & online services, and rapid increase in aging population who find it difficult to visit pharmacies. Convenience, affordability, and ease in availability of medicines are fueling market growth.

Increase in prevalence of chronic conditions and diseases across the globe is resulting in constant growth in demand for various drugs and healthcare products. High cost of treatment is indicating the need to reduce health care cost. Online pharmacies are gaining popularity owing to lucrative offers such as price discounts that result in cost savings. In addition, increase in adoption of e-prescriptions in hospitals and other healthcare facilities is further expected to boost growth.

High-unmet needs of emerging economies is one of the key driving factors. Government initiatives, increase in investments, changing regulations, and increasing penetration of internet and broadband in urban as well as rural areas are contributing to the growth of the market. Many new players are entering the market as the healthcare sector is offering huge potential to the online health retailers due to the ever-growing demand for healthcare products and services.

However, growth in illegal online pharmacies is restraining the growth. These illegitimate websites may offer counterfeit and unapproved drugs, which make people skeptical about purchasing medicines online.

Full Research Report on Global E-Pharma Market Analysis:
http://www.grandviewresearch.com/industry-analysis/e-pharma-market

Further Key Findings From the Report Suggest:

• North America held majority of the share in 2016 due to increase in online purchases, growing elderly population, and high adoption of IT in healthcare
• The U.S. is the largest market in North America owing to the presence of various key players and a large tech-savvy population
• Asia Pacific is expected to be the fastest growing segment due to the presence of emerging economies like China & India and improving infrastructure

• Some of the key players are The Kroger Co., Walgreen Co.; Wal-Mart Stores, Inc.; CVS Health; Express Scripts Holding Company; Giant Eagle, Inc.; DocMorris (Zur Rose Group); Rowlands Pharmacy; and OptumRx, Inc.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global E-Pharma Market on the basis of region:

e-Pharma Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-e-pharma-market                 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

In-vitro Toxicology Testing Market Is Expected To Reach $44.7 Billion By 2022

Global In-Vitro Toxicology Testing Market is expected to reach USD 44.7 billion by 2022 growing at an estimated CAGR of 10.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected rise in demand can be ascribed to novel and promising technologies in analytical laboratories. 

Advancement in bioinformatics based research for development of efficient software algorithms in order to carry out efficient stimulation of in-silico animal models in determination of toxicological response is expected to influence sector growth through to 2022. 

Furthermore, rapid up gradation of databases that serve information for toxicity profiling and lethal dose determination of different compounds is anticipated to create significant potential for growth in this market during the forecast period. 

Rise in government imposed restrictions and guidelines on usage of animals for pre-clinical research and toxicology testing is also attributive towards estimated progress in this industry.

Additionally, increasing R&D in biotechnology sector for enhancement in cell based assays and cell culture techniques, is anticipated to impart significant growth potential in this sector. 

Full Research Report on Global In-vitro Toxicology Testing Market Analysis:
http://www.grandviewresearch.com/industry-analysis/in-vitro-toxicology-testing-market

Further key findings from the study suggest:

• Pharmaceutical and cosmetic industry together accounted for almost 65% of total revenue generated in this sector for 2014. This large share can be attributed to rapid novel product launches for treatment of different diseased conditions wherein toxicological testing is the pre-requisite step. 

• Cell culture technology contributed for over 42% of the revenue generated in the industry with respect to technology owing to critical role of cell culture in biotechnological development and cell based analysis 

• Omics technology is anticipated to register lucrative growth thereby driving demand due to advancement in sequencing methods and availability of different platforms depending on source and target sequence. 

• As a fundamental process in biopharmaceutical or pharmaceutical product development toxicological testing finds application in determination of systemic, dermal, & ocular toxicity as well as endocrine disruption 

• Amongst the above enlisted applications, dermal toxicity is expected to witness significant progress with a CAGR of approximately 13% due to comparatively higher incidence of side effects associated with skin after administration of several compounds. 

• North America accounted for the largest share of over 45% in revenue in 2014 owing to presence of significant number of sector players that are implementing advanced in-vitro technology. Furthermore, presence of stringent regulations pertaining to animal usage in toxicity analysis attributive towards high demand of in-vitro tests in this region. 

• Asia Pacific is expected to witness lucrative CAGR of over 11% from 2015 to 2022 due to rapid improvement in health care infrastructure in developing economies of this region which in turn contributes to regional progress in industry. 

• Key participants of in-vitro toxicology testing industry are Quest Diagnostics, Covance, Cyprotex, Alere, Inc, Charles River Laboratories, GE Healthcare, Thermo Fisher Scientific, Eurofins Scientific, Inc., Agilent Technologies, Catalent Pharma Solutions, Sigma Aldrich, and Bio-Rad. 

• These participants are involved in collaborations with bioinformatics research firms in order to develop novel in-silicoalgorithms for computational estimation of toxicity of pharmaceutical and chemical products. 

• Moreover, these market entities are also focusing on entering untapped regions in order to maintain their share in market revenue. 

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented Global In-Vitro Toxicology Testing Market on the basis of end use, technology, method, application, and region:

Global In-vitro Toxicology Testing Outlook, by End-use (Revenue, USD Million, 2012 - 2022)

• Pharmaceutical industry
• Cosmetics & household products
• Diagnostics
• Chemical industry
• Food industry

Global In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)

• Cell culture technology
• High throughput technology
• Molecular imaging
• OMICS technology

Global In-vitro Toxicology Testing Outlook, by Application (Revenue, USD Million, 2012 - 2022)

• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Occular toxicity

Global In-vitro Toxicology Testing Outlook, by Method (Revenue, USD Million, 2012 - 2022)

• Cellular Assay
• Biochemical Assay
• In-Silico
• Ex-vivo

In-vitro Toxicology Testing Regional Outlook (Market Revenue in USD Million, 2012 - 2022 )

• North America
• Europe
• Asia Pacific
• RoW

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-in-vitro-toxicology-testing-market                

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information, visit us: www.grandviewresearch.com

Apheresis Equipment Market Is Projected To Growing At A CAGR Of 11.5% During The Forecast Period 2013-2024

Global Apheresis Equipment Market is expected to reach USD 3.7 billion by 2024, according to a new report by Grand View Research, Inc. The apheresis equipment industry is expected to be impacted by factors such as rising demand for plasma, platelets and other blood components, increasing incidence of chronic illnesses, presence and development of ideal reimbursement policies across various regions, and supportive government initiatives.

The U.S. Federal Government has been very involved in the funding of apheresis research through its benefit programs such as Medicare, Medicaid, veterans’ health administration military and employee insurance programs. Medicare provides coverage for apheresis regardless of whether the procedure is performed in a hospital or a blood center. In addition, private insurers have recently begun to closely examine apheresis procedures and issue policy statements pertaining to coverage.

Growing incidence of blood related disorders leading to the rise in demand for platelets and plasma is expected to serve the market as a high impact rendering driver. The industry is also expected to be driven by technology innovations aimed at delivering relatively more effective and faster results. Healthcare practitioners and researchers are now in the need for devices requiring minimum human intervention and introduction of fully automatic apheresis equipment with enhanced displays is expected to improve usage rates.

Full Research Report on Global Apheresis Equipment Market Analysis:
http://www.grandviewresearch.com/industry-analysis/apheresis-equipment-market

Further Key Findings From the Study Suggest:

• Disposable apheresis kits are anticipated to dominate the product segment by 2024. Bulk volume purchase associated with these products is predicted to govern their growth.A single cycle of apheresis procedure consumes multiple disposable sub parts which is responsible for comparatively larger market volume as compared to apheresis machines.
• The photopheresis procedure is anticipated to witness lucrative growth owing to its rising demand in treatment. The procedure is approved for treatment of solid organ transplant rejection, scleroderma, type 1 diabetes, pemphigus vulgaris, lichen planus &atopic dermatitis, and cutaneous T-cell lymphoma.
• Another procedure expected to gain lucrative share is erythrocytapheresis. The procedure also finds application in blood donation procedures where it is widely used for separating two units of blood, known as double red cell apheresis. Rising incidence rates of genetic disorders such as sickle cell anemia is expected to drive market growth by widening the patient base.
• Asia Pacific is anticipated to witness the fastest growth over the forecast period. Presence of high unmet needs and rapidly increasing demand for platelets in the emerging Asia Pacific and Latin American markets is expected to serve this market as future growth opportunities. For example, in July, 2014, India witnessed a rapid rise in demand for platelets owing to an increased incidence rate of dengue.

• Key players of this industry include Fresenius Kabi; Haemonetics; Terumo BCT; Therakos, Inc.; Asahi Kasei Kuraray Medical Co Ltd; and B. Braun Melsungen AG. Strategies promoting faster distribution and development of efficient supply chain are being incorporated by the players.
• For instance, in March 2014, Therakos, Inc., signed an exclusive distribution agreement with Terumo BCT, wherein Terumo would be the sole supplier of UVAR XTS and THERAKOS CELLEX in the Latin American region. Countries such as Mexico, Argentina, Peru, Colombia and Uruguay would be under purview.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Apheresis Equipment Market on the basis of product, application, procedure, technology and region.

Global Market by Product , 2013 - 2024 (USD Million)

• Disposable apheresis kits
• Apheresis machine

Global Market by Application , 2013 - 2024 (USD Million)

• Renal diseases
• Hematology
• Neurology
• Others

Global Market by Procedure , 2013 - 2024 (USD Million)

• Plasmapheresis
• LDL-apheresis
• Plateletpheresis
• Leukapheresis
• Photopheresis
• Erythrocytapheresis
• Others

Global Market by Technology , 2013 - 2024 (USD Million)

• Membrane Filtration
• Centrifugation

Global Market by Region , 2013 - 2024 (USD Million)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-apheresis-equipment-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information, visit us: www.grandviewresearch.com

Zeolite Molecular Sieve Market Is Expected To Grow At A CAGR 2.3% From 2015 To 2022

Global Zeolite Molecular Sieve Market is expected to reach USD 4.27 billion by 2022, according to a new study by Grand View Research, Inc. Increasing demand for energy coupled with stress on green technologies has resulted in growing demand for zeolite molecular sieves as catalysts for petroleum refining. Higher efficiency and yield, and non-toxicity property of zeolites has resulted in the extensive use of the mineral for catalytic operations. In addition, growing demand for adsorbents owing to rising awareness regarding presence of hazardous organic materials in wastewater is expected to augment zeolite molecular sieve market demand over the forecast period.

Detergents accounted for over 70% of the global zeolite molecular sieve market volume share in 2014. Zeolite molecular sieves are used in detergents owing to its ability to produce demineralized water through calcium ion exchange which helps in the removal of any kind of dirt. This has resulted in a tremendous demand for zeolite molecular sieves from detergent segment. Zeolite molecular sieves being increasingly used in the petroleum industry as catalysts which is anticipated to drive market growth.

Full Research Report on Global Zeolite Molecular Sieve Market Analysis:
http://www.grandviewresearch.com/industry-analysis/synthetic-zeolite-market

Further key findings from the study suggest:

• Global zeolite molecular sieve demand in catalysts was 345.7 kilo tons in 2014 and is expected to grow at a CAGR 2.3% from 2015 to 2022. Increasing industrial use of zeolite molecular sieve as catalysts in the petroleum industry has resulted in driving market growth over the past few years and the trend is anticipated to continue over the forecast period. Zeolite molecular sieves are used for cracking of petroleum as it causes certain structural changes during the chemical reaction which helps in manufacturing petrochemicals.
• Asia Pacific is expected to be a lucrative market, which accounted for 32.0% of global zeolite molecular sieve market volume in 2014. Growing demand for refrigerants and detergents, and an increasing utilization of zeolites in advanced processing methods in nuclear industry for the removal of nuclear waste is expected to have a positive impact in the region over the forecast period.
• In 2013, global natural zeolite mining output exceeded 2,700 kilo tons, where China was the largest producer accounting for over 70% of the output. China was the largest consumer for natural zeolites in 2014, owing to the presence of a well-established manufacturing base for detergents, petroleum refining, gas separation and water purification.
• Kay players present in the global zeolite molecular sieve market include Tosoh Corporation, Arkema, BASF, UOP, Grace Catalysts Technologies, Zeox Corporation, Chemiewerk Bad Köstritz and Union Showa K K. the global market is characterized by integration across raw materials and manufacturing stages of the value chain.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/catalysts-and-enzymes

For the purpose of this study, Grand View Research has segmented the Global Zeolite 

Molecular Sieve Market on the basis of application and region:

• Global Zeolite Molecular Sieve Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)
• Detergents
• Catalysts
• Others
• Global Zeolite Molecular Sieve Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

·         North America

§  U.S.

·         Europe

§  Russia

§  Turkey

·         Latin America

§  Brazil

·         Asia Pacific

§  China

§  India

·         MEA

§  Qatar

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-zeolite-molecular-sieve-market              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information, visit us: www.grandviewresearch.com

Artificial Organ And Bionics Market Is Projected To Grow At An Estimated CAGR Of 9.3% From 2014 To 2020

Global Artificial Organ And Bionics Market is expected to reach USD 38.75 billion by 2020 at an estimated CAGR of 9.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of acute renal failure and renal disorders due to lifestyle habits such as excessive alcohol consumption and growing geriatric population base causing a rise in organ failure rates is expected to serve this market as a high impact rendering driver. In addition, growing incidence rates of accidents is expected to boost the demand for organ transplants, thus increasing demand for artificial organ. Artificial kidney dominated the global market in 2013, with revenue estimated at over USD 12.21 billion; demand is expected grow due to the increasing chronic kidney patients. Artificial liver is the fastest growing market

Full Research Report on Global Artificial Organ And Bionics Market Analysis
http://www.grandviewresearch.com/industry-analysis/artificial-organ-and-bionics

Further key findings from the study suggest:

• Brain bionics in the medical bionics market held the largest share of revenue for the year 2013 and the market is expected to grow at an estimated CAGR of 40.0%.The presence of high unmet medical needs in neurology disease segment coupled with expensive treatment procedures is expected to drive the market for brain bionics. Exoskeleton is the fastest growing segment and is expected to grow at a CAGR of 16.0% from 2014 to 2020.

• North America was the largest regional market in 2013, accounting for over 42.0% of global revenue due to the increasing population and awareness among the patients and the players.

• Asia Pacific is the fastest growing market and is expected to grow at a CAGR of 11.0% from 2014 to 2020 on account of rising demand due to the improvement in healthcare facilities, medical tourism and others.Increasing income levels and healthcare expenditure is expected to interest of the players’ in the emerging markets.

• Key industry participants include Abiomed Inc., Asahi Kasei Kuraray Medical Co. Ltd., Thoratec Corporation, WorldHeart Corp., Gambro AB and others.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global Artificial Organ And Bionics Market on the basis of product, technology and region:

Artificial Organ Product Outlook

• Artificial organs

·         Total artificial heart

·         Artificial liver

·         Artificial pancreas

·         Artificial lungs

·         Artificial kidney

• Bionics

·           Cochlear implants

·           Exoskeletons

·           Cardiac bionics

§  Heart valves

§  Biological tissue valves

§  Mechanical valves

§  Transcatheter heart valves

·         Ventricular assist device

·         Bionic limbs

·         Bionic legs

·         Bionic hands

·         Brain bionics

·         Deep brain stimulators

·         Spinal cord stimulators

·         Vagus nerves stimulators

·         Vision bionics

Artificial Organ Technology Outlook

• Mechanical bionics
• Electronic bionics

Artificial Organ Regional Outlook

• North America
• Europe
• Asia Pacific
• RoW

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-artificial-organ             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information, visit us: www.grandviewresearch.com

Enterprise Wearable Industry Outlook By Executive Summary, Market Variables, Trends And Scope 2014-2025

Global Enterprise Wearable Market is expected to reach USD 22.3 billion by 2025, according to a new study conducted by Grand View Research, Inc. The high demand for enterprise wearable devices in the Asia Pacific region is anticipated to drive the industry growth over the next decade. The aging population and rising chronic diseases, such as coronary heart diseases and diabetes, in countries such as China, India, and Japan would drive the demand for wearable technology in the region.

Industry players are investing a significantly in research & development activities for product innovation, thus catering to the specific needs of the enterprise industry. They are using strategies such as acquisition, partnerships, and collaborations to maintain market competencies.

The rising enterprise applications of Virtual Reality (VR) and Augmented Reality (AR) in the following years is expected to fuel the demand for wearable devices, such as smart eye wear and head mounted devices.  This growth in demand may be attributed to advancements in the VR and AR technologies, which would help increase their connectivity and enterprises’ interaction with employees and consumers.

The increasing awareness regarding health and wellness, rising aging population, and chronic diseases such as heart attack and diabetes, globally, are favorable factors expected to support the demand for wearable devices over the forecast period.

The rising demand for IoT technology, owing to its wide application in various sectors such as healthcare, manufacturing, retail, and others, is foreseen to drive the growth of the enterprise wearable market. The IoT technology, along with wearable devices, would help organizations in the development and deployment of the future generation value-added services by utilizing user-centric data.

Full Research Report on Global Enterprise Wearable Market Analysis:
http://www.grandviewresearch.com/industry-analysis/the-global-enterprise-wearables-market

Further key findings from the study suggest:

• The IoT technology segment is expected to surpass the Bluetooth segment and dominate the market after 2022 as well. This growth may be attributed to the expected rise of widespread real-time applications of IoT technology in different industries globally over the next decade.
• The demand for head wear devices is expected to gain momentum over the forecast period owing to their prospective applications in highly developing technologies such as VR and AR
• The Asia Pacific region is predicted to emerge as the fastest growing market owing to a significant rise in the number of adopters of medical wearable devices for monitoring bodily conditions, such as glucose level, heart condition, temperature, sleep, and others, in countries such as China and India
• Prominent vendors operating in the market include Fitbit Inc., Apple Inc., Alphabet Inc., Xiaomi Inc., Samsung Electronics Co. Ltd., Eurotech SpA, Adidas AG, and Seiko Epson Corporation
• The increased focus on research and development activities for new product developments and upgrades of existing products to meet industry demands are the key trends adopted by industry player

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the Global Enterprise Wearable Market on the basis of technology, product, application, and region:

Technology Outlook (Revenue, USD Million; 2014 - 2025)

• IoT
• Bluetooth
• Bluetooth Low Energy (BLE)

Product Outlook (Revenue, USD Million; 2014 - 2025)

• Wrist-wear
• Foot wear
• Eye wear
• Arm wear
• Head wear

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Infotainment
• Healthcare
• IT & telecom
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• Japan
• India
• Latin America
• Brazil
• Mexico
• Middle East & Africa

View Blog On This Research Report By Grand View Research: http://www.grandviewresearch.com/blog/enterprise-wearables-size-share             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information, visit us: www.grandviewresearch.com

Healthcare Biometrics Market Is Expected To Witness A CAGR Of 24.1% Over The Forecast Period 2013-2024

Global Healthcare Biometrics Market is expected to reach USD 11.7 billion by 2024, according to a new report by Grand View Research, Inc. The demand for biometric systems in the healthcare market is expected to surge due to the rising cases of medical identity thefts, the most predominant form of healthcare fraud jeopardizing patient health, and the resultant government initiatives favoring digitalization of healthcare systems. 

Associated benefits, such as data protection, elimination of the need of physical supervision, advanced security protocols, and strengthened patient trust & reliability, are certain vital impact rendering factors propelling the growth of these systems in the healthcare industry. 

Also, establishment of federal laws, such as the Electronic Protected Health Information and Health Insurance Portability and Accountability acts are expected to propel the demand for these advanced biometric systems.

Full Research Report on Global Healthcare Biometrics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/biometrics-in-healthcare-market

Further key findings from the study suggest:

• Based on technology, the healthcare biometrics market has been fragmented into face recognition, fingerprint analysis, iris recognition, vein recognition, palm geometry recognition, behavioral recognition, and others. Technologies such as DNA analysis and retina scanning-based solutions are expected to witness the fastest growth over the forecast period.
• The other technologies segment is anticipated to grow at a CAGR of about 27.0%, which is attributable to the rapid development of DNA-based recognition systems and their incorporation within the healthcare field
• The behavioral recognition technology is further classified into voice recognition, signature recognition, and others. The voice recognition segment is expected to witness lucrative growth over the forecast period due mainly to the technology advancements comprising miniaturization and greater processing power.
• Systems with the ability to identify voice prints are being developed, for instance, Amerigroup Community Care of Florida aims to acquire a voice biometric solution for its Indian policy holders to overcome security lapses in telephonic communication
• Based on region, North America is expected to dominate the market whereas Asia Pacific is anticipated to witness the fastest growth over the forecast period. The growth drivers in both these regions are similar, however, the presence of well-established infrastructure and digitalized platforms in North America are responsible for the high market share. By 2024, the Asia Pacific region is expected to contribute to over 20.0% of the revenue.
• Some of the major industry players include BIO-key International, NEC Corporation, Imprivata, Inc., Fujitsu, Crossmatch, Suprema, 3M, HID Biometric, and MorphoTrust. New product launches and rising R&D efforts directed toward technology refinements by these companies will be witnessed over the forecast period.
• Imprivata, Inc., approved the certification of their palm scan-based biometric platform PatientSecure, developed as a kiosk center whereby patients may identify themselves and register an appointment for one or more of the services offered at the respective healthcare facility. The approval was granted in July 2016 after it was showcased at the Healthcare Information and Management Systems Society conference. 

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Healthcare Biometrics Market on the basis of technology and region.

Global Healthcare Biometrics Market by Technology (USD Million), 2013 - 2024

• Face Recognition
• Fingerprint Recognition
• Iris Recognition
• Vein Recognition
• Palm Geometry Recognition
• Behavioral Recognition

·         By technology

§  Signature recognition

§  Voice recognition

§  Others

By Type

§  Single factor authentication

§  Multi-factor authentication

§  Multi-modal authentication

·         Others

Healthcare Biometrics Market by Region (USD Million), 2013 - 2024

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Saudi Arabia

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-biometrics-in-healthcare-market             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information, visit us: www.grandviewresearch.com